Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project - PubMed (original) (raw)
. 2010 Jul;19(7):1737-45.
doi: 10.1158/1055-9965.EPI-10-0230.
Annekatrin Lukanova, Håkan Jonsson, Steinar Tretli, Hanno Ulmer, Jonas Manjer, Tanja Stocks, Randi Selmer, Gabriele Nagel, Martin Almquist, Hans Concin, Göran Hallmans, Christel Häggström, Pär Stattin, Anders Engeland
Affiliations
- PMID: 20615887
- DOI: 10.1158/1055-9965.EPI-10-0230
Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project
Tone Bjørge et al. Cancer Epidemiol Biomarkers Prev. 2010 Jul.
Abstract
Background: Few studies have assessed the metabolic syndrome (MetS) as an entity in relation to breast cancer risk, and results have been inconsistent. We aimed to examine the association between MetS factors (individually and combined) and risk of breast cancer incidence and mortality.
Methods: Two hundred ninety thousand women from Austria, Norway, and Sweden were enrolled during 1974-2005, with measurements of height, weight, blood pressure, and levels of glucose, cholesterol, and triglycerides. Relative risks (RR) of breast cancer were estimated using Cox proportional hazards regression for each MetS factor in quintiles and for standardized levels (z-scores) and for a composite z-score for the MetS.
Results: There were 4,862 incident cases of breast cancer and 633 deaths from breast cancer identified. In women below age 50, there was a decreased risk of incident cancer for the MetS (per 1-unit increment of z-score; RR, 0.83; 95% confidence interval, 0.76-0.90) as well as for the individual factors (except for glucose). The lowest risks were seen among the heaviest women. In women above age 60, there was an increased risk of breast cancer mortality for the MetS (RR, 1.23; 95% confidence interval, 1.04-1.45) and for blood pressure and glucose. The strongest association with mortality was seen for increased glucose concentrations.
Conclusions: The MetS was associated with a decreased risk of incident breast cancer in women below age 50 with high body mass index, and with an increased risk of breast cancer mortality in women above 60.
Impact: Lifestyle interventions as recommended for cardiovascular disease prevention may be of value to prevent breast cancer mortality in postmenopausal women.
Similar articles
- Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Jonsson H, Häggström C, Stattin P, Engeland A. Bjørge T, et al. Int J Epidemiol. 2011 Dec;40(6):1667-77. doi: 10.1093/ije/dyr130. Epub 2011 Oct 7. Int J Epidemiol. 2011. PMID: 21984693 - Metabolic syndrome and endometrial carcinoma.
Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Bjørge T, et al. Am J Epidemiol. 2010 Apr 15;171(8):892-902. doi: 10.1093/aje/kwq006. Epub 2010 Mar 10. Am J Epidemiol. 2010. PMID: 20219764 - Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
Ulmer H, Bjørge T, Concin H, Lukanova A, Manjer J, Hallmans G, Borena W, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stattin P, Tretli S, Kleiner A, Stocks T, Nagel G. Ulmer H, et al. Gynecol Oncol. 2012 May;125(2):330-5. doi: 10.1016/j.ygyno.2012.01.052. Epub 2012 Feb 10. Gynecol Oncol. 2012. PMID: 22330614 - Metabolic syndrome and breast cancer: an overview.
Gezgen G, Roach EC, Kizilarslanoglu MC, Petekkaya I, Altundag K. Gezgen G, et al. J BUON. 2012 Apr-Jun;17(2):223-9. J BUON. 2012. PMID: 22740197 Review. - Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies.
Liu CF, Zhou WN, Fang NY. Liu CF, et al. Int J Clin Pract. 2012 Jul;66(7):692-8. doi: 10.1111/j.1742-1241.2012.02959.x. Int J Clin Pract. 2012. PMID: 22698421 Review.
Cited by
- Link Between Metabolic Syndrome, Blood Lipid Markers, Dietary Lipids, and Survival in Women with Early-Stage Breast Cancer.
Bobin-Dubigeon C, Campion L, Bossard C, Rossignol E, Frenel JS, Campone M, Bard JM. Bobin-Dubigeon C, et al. Nutrients. 2024 Oct 22;16(21):3579. doi: 10.3390/nu16213579. Nutrients. 2024. PMID: 39519412 Free PMC article. - The consumption of Sechium edule (chayote) has antioxidant effect and prevents telomere attrition in older adults with metabolic syndrome.
Gavia-García G, Rosado-Pérez J, Arista-Ugalde TL, Aguiñiga-Sánchez I, Santiago-Osorio E, Mendoza-Núñez VM. Gavia-García G, et al. Redox Rep. 2023 Dec;28(1):2207323. doi: 10.1080/13510002.2023.2207323. Redox Rep. 2023. PMID: 37140004 Free PMC article. - Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study.
Sun M, Fritz J, Häggström C, Bjørge T, Nagel G, Manjer J, Engeland A, Zitt E, van Guelpen B, Stattin P, Ulmer H, Stocks T. Sun M, et al. J Natl Cancer Inst. 2023 Apr 11;115(4):456-467. doi: 10.1093/jnci/djad008. J Natl Cancer Inst. 2023. PMID: 36647199 Free PMC article. - An Updated Systematic Review and Meta-Analysis on Association of Serum Lipid Profile With Risk of Breast Cancer Incidence.
Amerizadeh A, Vaseghi G, Farajzadegan Z, Asgary S. Amerizadeh A, et al. Int J Prev Med. 2022 Nov 23;13:142. doi: 10.4103/ijpvm.IJPVM_285_20. eCollection 2022. Int J Prev Med. 2022. PMID: 36618541 Free PMC article. Review. - Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea.
Jo H, Kim SI, Wang W, Seol A, Han Y, Kim J, Park IS, Lee J, Yoo J, Han KD, Song YS. Jo H, et al. Front Oncol. 2022 Jun 16;12:872995. doi: 10.3389/fonc.2022.872995. eCollection 2022. Front Oncol. 2022. PMID: 35785211 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical